Clinical trial
Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated…
NCT03608397 · Revance Therapeutics, Inc., Industry · Completed
Key facts
| NCT number | NCT03608397 |
|---|---|
| Title | Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1) |
| Official title | A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial to Evaluate the Efficacy and Safety of a Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1) |
| Acronym | ASPEN-1 |
| Lead sponsor | Revance Therapeutics, Inc., Industry |
| Collaborators | Syneos Health |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cervical Dystonia |
| Intervention type | Biological |
| Interventions | DaxibotulinumtoxinA for injection, Placebo |
| Enrollment | 301 |
| Start date | Jun 20, 2018 |
| Primary completion | Dec 3, 2019 |
| Completion | Jun 16, 2020 |
| First posted | Aug 1, 2018 |
| Last update posted | Dec 5, 2022 |
| Countries | Austria, Canada, Czechia, France, Germany, Poland, Spain, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: